NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 198 filers reported holding NOVOCURE LTD in Q2 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $24,386,000 | 14.72% |
HARTLINE INVESTMENT CORP/ | 335,191 | $58,001,000 | 8.32% |
Deep Track Capital, LP | 1,341,300 | $93,220,000 | 6.13% |
MORGAN JESS S & CO INC | 48,345 | $3,360,000 | 3.48% |
Taylor Frigon Capital Management LLC | 68,908 | $4,789,000 | 2.49% |
HighVista Strategies LLC | 28,007 | $1,946,000 | 1.18% |
Private Harbour Investment Management & Counsel, LLC | 13,106 | $911,000 | 1.01% |
Lloyd Park, LLC | 9,325 | $648,000 | 0.68% |
Baillie Gifford | 9,116,230 | $633,578,000 | 0.65% |
HAP Trading, LLC | 110,900 | $10,575,000 | 0.53% |